First EUL granted by WHO for a protein-based COVID-19 vaccine
EUL vaccine manufactured and marketed by SII as COVOVAX™
WHO EUL for Nuvaxovid™ currently under assessment; will be completed following
Wabtec Corporation (NYSE: WAB) today announced it recently acquired the railway friction business from MASU, a leading manufacturer of friction products across the automotive and rail industry.